| New challenges in targeting signaling pathways in acute lymphoblastic leukemia by NGS approaches: an update A Montaño, M Forero-Castro, D Marchena-Mendoza, R Benito, ... Cancers 10 (4), 110, 2018 | 50 | 2018 |
| Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia M Quijada-Álamo, M Hernández-Sánchez, C Robledo, ... Journal of hematology & oncology 10, 1-11, 2017 | 50 | 2017 |
| Targeted genome editing in acute lymphoblastic leukemia: a review A Montaño, M Forero-Castro, JM Hernández-Rivas, I García-Tuñón, ... BMC biotechnology 18, 1-10, 2018 | 24 | 2018 |
| ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia A Montaño, JL Ordoñez, V Alonso-Pérez, J Hernández-Sánchez, ... Cells 9 (1), 215, 2020 | 22 | 2020 |
| Comprehensive custom NGS panel validation for the improvement of the stratification of B-acute lymphoblastic leukemia patients A Montaño, J Hernández-Sánchez, M Forero-Castro, M Matorra-Miguel, ... Journal of Personalized Medicine 10 (3), 137, 2020 | 5 | 2020 |
| Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia N Vega-Garcia, R Benito, E Esperanza-Cebollada, M Llop, C Robledo, ... Journal of Personalized Medicine 10 (4), 244, 2020 | 3 | 2020 |
| Etv6/Runx1 Fusion Gene Abrogation Decreases The Oncogenic Potencial Of Tumour Cells In A Preclinical Model Of Acute Lymphoblastic Leukaemia A Montaño, JL Ordoñez, V Alonso-Pérez, J Hernández-Sánchez, ... bioRxiv, 809525, 2019 | | 2019 |
| PF170 ETV6/RUNX1 FUSION GENE ABROGATION DECREASE THE ONCOGENIC POTENCIAL OF TUMORS CELLS IN A PRECLINICAL MODEL OF ACUTE LYMPHOBLASTIC LEUKEMIA A Montaño, JL Ordóñez, V Alonso-Pérez, A Marín-Quílez, ... HemaSphere 3 (S1), 36-37, 2019 | | 2019 |
